Tag: myelodysplastic syndrome (MDS)

23-CNR-4044609-CQD-Hero-650×450 AML study
October 20, 2023/Research

The Role of Immune Escape in Post-Transplant Leukemia Relapse

Immunological pressure driving genetic mutations

Lab equipment centrifuging blood. Concept image of a blood test.3d rendering.
February 3, 2022/Blood Cancers

Newly Identified Risk Factors Help Predict How Aplastic Anemia Can Become Malignant

Study reveals characteristics that may spark the development of myelodysplastic syndrome and acute myeloid leukemia

leukemia_650x450

Succession of Molecular Lesions Critical to Leukemia Disease Development

Mutational pattern in MDS is not random, study finds

18-CCC-5885-DNA-PTA-test-650×450
January 15, 2020/Research

New Clinic Tackles Mutations That Increase Risk of Blood Cancers and Heart Disease

CHIP Clinic's goals: Research, preventive care

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

650×450-PICU2
July 15, 2019/Cancer

Survival Trends in Infant Allogeneic Cell Transplant Recipients: Limited Progress

Outcomes in youngest patients are mixed, reflecting clinical challenges

nci-vol-3696_650x450
March 25, 2019/Blood Cancers

Azacitidine Shows Potential in Treating AML and MDS Relapse Following Stem Cell Transplantation

May offer much needed treatment option for patients who relapse early

chemo-drug_650x450
December 2, 2018/Research

The Next Step in Immunotherapy for Myeloid Hematologic Malignancies

Study explores atezolizumab for myelodysplastic syndrome

BackPage 1 of 1Next
Advertisement
Ad